Past Papers · SAQ

Pulmonary Vasoconstriction & Inhaled Vasodilators

Current · V5 (2025) → C5.i 1 exam appearance

2026A Q12

Exam question

a) Describe the physiological factors that contribute to pulmonary vasoconstricton. Include the mechanisms involved in your answer (60% of marks). b) For each of the inhaled pulmonary vasodilators, nitric oxide and prostacyclin: i) describe the mechanism(s) of action (25% of marks) ii) outline the adverse effects (15% of marks).

CICMWrecks answer

Master answer

Master answer coming soon.

Past papers

Exam appearances

1 appearance
Exam Exact exam wording Candidate success
2026A Q12 a) Describe the physiological factors that contribute to pulmonary vasoconstricton. Include the mechanisms involved in your answer (60% of marks). b) For each of the inhaled pulmonary vasodilators, nitric oxide and prostacyclin: i) describe the mechanism(s) of action (25% of marks) ii) outline the adverse effects (15% of marks). 44.6%